MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.

Analysts told Decrypt though ETF approval rumors are adding to optimism, it’s MEI Pharma’s buy-in last month that is really ...

San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...

MEI Pharma (MEIP) just threw Wall Street a curveball by swapping part of its cash pile for Litecoin (LTC) and inviting Litecoin creator Charlie Lee onto its board. That decision comes via a ...

This strategic move, developed in partnership with GSR and with guidance provided by Litecoin Creator and MEI Board member Charlie Lee, marks the beginning of MEI’s broader institutional treasury ...

Litecoin (LTC), one of the oldest and most recognized cryptocurrencies, is showing renewed strength in the market, surging with institutional interest and ...

MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

MEI Pharma unveils a $100M Litecoin treasury initiative, gaining Litecoin Foundation support and boosting shares 50% intraday ...

GSR, crypto’s capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc. (NASDAQ ... MEI represents a significant step toward institutionalizing Litecoin as ...

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange ...

Home News Business Wire MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange ...

SAN DIEGO--(BUSINESS WIRE)-- MEI Pharma, Inc. (the “Company” or “MEI”) today announced that it has entered into securities purchase agreements for a private investment in public equity ...